Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062279
Company: VALEANT LUXEMBOURG
Company: VALEANT LUXEMBOURG
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| GRIFULVIN V | GRISEOFULVIN, MICROCRYSTALLINE | 125MG | TABLET;ORAL | Discontinued | None | No | No |
| GRIFULVIN V | GRISEOFULVIN, MICROCRYSTALLINE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | No | No |
| GRIFULVIN V | GRISEOFULVIN, MICROSIZE | 500MG | TABLET;ORAL | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 04/22/2014 | SUPPL-22 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/062279s022lbl.pdf |